- FDA advisory panel to consider OTC status of NSAIDs
- Prestige Brands solution to pediatric overdosing — unique squeezable, single-dose APAP packet
- FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose
- ROUNDTABLE: Pharmacy’s future in sync with technology
- Vitamins and Supplements 2014
MORRISTOWN, N.J. — Bayer HealthCare's Consumer Care Division on Tuesday introduced Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms like nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity) through a formulation of aspirin, acetaminophen and caffeine.
"Consumers have been extremely vocal about the lack of OTC options tough enough to target throbbing migraine pain," stated Reese Fitzpatrick, Bayer Aspirin director marketing. The new formula contains the same three active ingredients and dosages for migraine relief as Novartis' Excedrin Migraine, which became unavailable earlier this year, Bayer noted.
Bayer Migraine Formula will be packaged in a 50-count or 200-count bottle of coated caplets.